June 23, 2022 11:19
Korea is well prepared if monkeypox spreads here, though another pandemic of coronavirus proportions seems extremely unlikely.
Korea already has 35 million doses of second-generation monkeypox vaccines in case the disease should spread here. But a third-generation vaccine called Imbanex, developed by Bavarian Nordic of Denmark and causing fewer side effects than earlier versions, is not available here yet.
The second-generation vaccine must be administered within 14 days of suspected exposure to the virus.
A monkeypox treatment called Tecovirimat has also been developed by SIGA Technologies of the U.S. The government said it is in talks to bring in 5 million doses next month.
- Copyright © Chosunilbo & Chosun.com